Rossari Biotech Establishes Blending Facility in Thailand to Target Southeast Asian Market
Rossari Biotech Limited has expanded its operational footprint with the establishment of a new blending facility in Thailand. This move is part of the company's strategy to enhance market reach and manufacturing capability across Southeast Asia.The facility was set up by Unistar Thai Co. Limited, which operates under the umbrella of Rossari Global FZCO, a wholly owned subsidiary of Rossari Biotech Limited. The acquisition of 100% equity share capital in Unistar Thai Co. Limited was completed on December 10, 2024.
The newly established facility is strategically positioned to function as a regional technical hub. This positioning allows the Company to address the growing Southeast Asian market with agility by providing customized formulations tailored to local requirements.
The blending facility offers flexible manufacturing capabilities across various formats, including powders, granules, and liquids. To ensure supply chain resilience and operational efficiency, the site also includes dedicated storage capacity for surfactants and other key raw materials.
Key details regarding the new regional hub are as follows:
| Detail | Specification |
|---|---|
| Facility Location | Thailand |
| Installed Capacity | 5000 MTPA |
| Land Area Size | Approximately 1,860 square meters |
| Core Capability | Flexible manufacturing (powders, granules, liquids) |
This expansion supports the company's commitment to operational efficiency and strengthens its presence in the dynamic Southeast Asian market.
ROSSARI Stock Price Movement
Shares of Rossari Biotech Limited slipped by 1.15% to close at ₹534.85 on Thursday, reflecting a drop of ₹6.20 from the previous session's close. The stock traded within a narrow range of ₹530 and ₹546.9, with total volume reaching 104,717 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.